Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.covid19.nih.gov/

Division of Cancer Prevention
Division of Cancer Prevention

Search form

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Consortium for Imaging and Biomarkers (CIB)
    • Liquid Biopsy Consortium
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
    • Research Networks Map
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • Director
    • DCP Leadership
    • History and Timeline
    • Historical Resources
    • Staff Directory

You are here

  1. Home
  2.   »  Research Groups
  3.   »  Gastrointestinal and Other Cancers

Gastrointestinal and Other Cancers

Research Groups

  • Biometry
  • Breast and Gynecologic Cancer
  • Cancer Biomarkers
  • Chemopreventive Agent Development
  • Community Oncology and Prevention Trials
  • Early Detection
  • Gastrointestinal and Other Cancers
    • About the Gastrointestinal and Other Cancers Research Group
    • Active Grants
    • Clinical Trials
    • Funding Opportunities
    • Publications
    • Staff
  • Lung and Upper Aerodigestive Cancer
  • Nutritional Science
  • Prostate and Urologic Cancer

Contact the Gastrointestinal and Other Cancers Research Group

Phone: 240-276-7070
Fax: 240-276-7848

For Regular Mail

Gastrointestinal & Other Cancers Research Group
Division of Cancer Prevention National Cancer Institute
9609 Medical Center Drive
MSC 9782
Bethesda, MD 20892-9782

For Courier Packages

Gastrointestinal & Other Cancers Research Group
Division of Cancer Prevention National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850

The Gastrointestinal and Other Cancers Research conducts and supports prevention and early detection research on colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers, as well as new approaches to clinical prevention studies including cancer immunoprevention.

Read more About the Gastrointestinal and Other Cancers Research Group.

Staff

Funding Opportunities

Active Grants

Clinical Trials

Publications

Barrett's Esophagus Translational Research Network (BETRNet)

Multi-disciplinary Research Centers collaborate to enhance understanding of Barrett's esophagus and prevent esophageal adenocarcinoma.

Read more about Barrett's Esophagus Translational Research Network (BETRNet)

Cancer Prevention Clinical Trials Network (CP-CTNet)

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

More about the Cancer Prevention Clinical Trials Network (CP-CTNet)

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Major medical research centers conduct systematic early clinical development of promising preventive agents.

More about the Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Follow us at:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®